Antibody Drug Conjugates Market Overview, Growth Forecast, Demand And Development Research Report To 2030

>

Antibody Drug Conjugates Market Overview, Growth Forecast, Demand and Development Research Report to 2030

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects.

To order this 600+ page report, which features 190+ figures and 280+ tables, please visit this link

The USD 15 billion (by 2030) financial opportunity within this market has been analyzed across the following segments:

Type of Payload

  • MMAE
  • DM4
  • Camptothecin
  • DM1
  • MMAF
  • Others

Type of Linker

  • VC
  • Sulfo-SPDB
  • SMCC
  • VA
  • Hydrazone
  • Others

Target Indication

  • Breast cancer
  • Lymphoma
  • Leukemia
  • Urothelial cancer
  • Lung cancer
  • Ovarian cancer
  • Others

Target Antigen

  • CD30
  • HER2
  • CD22
  • CD33
  • Others

Technology Providers

  • Seattle Genetics
  • ImmunoGen
  • StemCentRx
  • Immunomedics
  • Others

Key Geographical Regions

  • North America
  • Europe
  • Asia Pacific

The Antibody Drug Conjugates Market (5th Edition), 2019-2030 report features the following companies, which we identified to be key players in this domain:

  • Bristol Myers Squibb
  • GlaxoSmithKline
  • Incyte
  • Novartis
  • Trillium Therapeutics

Table of Contents

  1. Preface
  2. Executive Summary
  3. Introduction

4.Market Overview

  1. Company and Drug Profiles
  2. Key Therapeutic Areas
  3. Key Opinion Leaders
  4. Target Competitiveness Analysis
  5. Partnerships and Collaborations
  6. Funding and Investment Analysis
  7. Patent Analysis
  8. Academic Grants
  9. Key Commercialization Strategies
  10. Promotional Analysis
  11. Combination Therapies
  12. Novel Conjugation Technology Platforms
  13. Assessment of Non-Clinical Data, First in Human Dosing
  14. Cost Price Analysis
  15. Case Study: Contract Manufacturing of ADC
  16. Case Study: Companion Diagnostics for ADC Therapeutic
  17. Market Forecast and Opportunity Analysis
  18. Swot Analysis
  19. Conclusion
  20. Executive Insights
  21. Appendix 1: Tabulated Data

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/antibody-drug-conjugates-market-5th-edition-2019-2030/270.html    

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

Gaurav.Chaudhary@rootsanalysis.com

Share:

Keywords: antibody drug conjugates market

Comments

Other related blogs

Driven Emergency Lights From Smart Lighting Industries Available

By : Smart Lighting Industries

Emergency lights have progressed from being a single light bulb framed in a rotating dome, to very i..


RNAi Therapeutics Market Analysis: Recent Trends and Regional Growth Forecasts 2020 to 2030

By : Roots Analysis

Roots Analysis has done a detailed study on RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Foc..


Luxury Handmade Designer Jewelry - Beads U Workshop

By : Beadsuworkshop

Growing up in the eastern Himalayas, Beth fell in love with countless alpine plants and gorgeous flo..


Luxury Handmade Designer Jewelry - Beads U Workshop

By : Beadsuworkshop

Growing up in the eastern Himalayas, Beth fell in love with countless alpine plants and gorgeous flo..